PARMEGGIANI, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 13.489
EU - Europa 8.171
AS - Asia 7.058
SA - Sud America 1.185
Continente sconosciuto - Info sul continente non disponibili 283
AF - Africa 186
OC - Oceania 30
Totale 30.402
Nazione #
US - Stati Uniti d'America 13.109
IT - Italia 4.313
SG - Singapore 2.498
CN - Cina 1.653
BR - Brasile 864
VN - Vietnam 770
DE - Germania 733
UA - Ucraina 629
PL - Polonia 626
HK - Hong Kong 615
GB - Regno Unito 445
FI - Finlandia 381
TR - Turchia 356
BD - Bangladesh 338
FR - Francia 332
IN - India 183
RU - Federazione Russa 183
CA - Canada 181
JP - Giappone 155
AR - Argentina 127
MX - Messico 125
NL - Olanda 118
ID - Indonesia 115
SE - Svezia 115
ZA - Sudafrica 58
IQ - Iraq 54
EC - Ecuador 53
CO - Colombia 49
ES - Italia 46
TH - Thailandia 37
BE - Belgio 33
MY - Malesia 32
PH - Filippine 32
AT - Austria 31
RO - Romania 30
PK - Pakistan 29
UZ - Uzbekistan 27
CZ - Repubblica Ceca 26
AU - Australia 25
CH - Svizzera 25
CL - Cile 24
KE - Kenya 24
VE - Venezuela 24
SA - Arabia Saudita 22
EG - Egitto 19
KR - Corea 18
LT - Lituania 18
IL - Israele 17
TN - Tunisia 17
MA - Marocco 16
NP - Nepal 15
PY - Paraguay 15
AE - Emirati Arabi Uniti 14
JM - Giamaica 13
PE - Perù 13
PT - Portogallo 13
CR - Costa Rica 10
HN - Honduras 10
AZ - Azerbaigian 9
BG - Bulgaria 9
DO - Repubblica Dominicana 9
TW - Taiwan 9
AL - Albania 8
IR - Iran 8
JO - Giordania 8
UY - Uruguay 8
DK - Danimarca 7
GR - Grecia 7
IE - Irlanda 7
OM - Oman 7
RS - Serbia 7
BO - Bolivia 6
DZ - Algeria 6
ET - Etiopia 6
GT - Guatemala 6
KZ - Kazakistan 6
BB - Barbados 5
BY - Bielorussia 5
NG - Nigeria 5
NZ - Nuova Zelanda 5
SK - Slovacchia (Repubblica Slovacca) 5
CI - Costa d'Avorio 4
EU - Europa 4
KG - Kirghizistan 4
LB - Libano 4
NI - Nicaragua 4
SN - Senegal 4
SV - El Salvador 4
TZ - Tanzania 4
BA - Bosnia-Erzegovina 3
CG - Congo 3
GA - Gabon 3
GE - Georgia 3
KW - Kuwait 3
MT - Malta 3
MU - Mauritius 3
MW - Malawi 3
PS - Palestinian Territory 3
QA - Qatar 3
TT - Trinidad e Tobago 3
Totale 30.076
Città #
Singapore 1.574
Ashburn 1.412
Fairfield 1.063
San Jose 982
Woodbridge 977
Jacksonville 662
Houston 661
Warsaw 613
Hong Kong 596
Santa Clara 537
Chandler 499
Beijing 498
Council Bluffs 473
Milan 444
Seattle 418
Wilmington 397
Ann Arbor 396
Cambridge 349
Dallas 296
Rome 275
Munich 274
Izmir 237
Ho Chi Minh City 234
Los Angeles 213
New York 213
Helsinki 195
Nanjing 181
Hanoi 165
Princeton 157
Lauterbourg 140
Tokyo 138
Bologna 133
Boardman 113
Ferrara 112
San Diego 87
Naples 81
São Paulo 78
Bari 71
Mexico City 70
Shenyang 67
Jakarta 64
Shanghai 63
Chicago 61
Palermo 61
Orem 57
Toronto 56
Dong Ket 54
London 54
Florence 52
Montreal 52
Redwood City 50
Hefei 49
Nanchang 48
Jiaxing 47
Turin 45
Brooklyn 44
Turku 43
Chennai 42
Catania 41
Tianjin 41
Buffalo 40
Denver 40
Phoenix 40
Changsha 39
Verona 37
San Francisco 36
Da Nang 35
Haiphong 35
Moscow 34
Hebei 32
Atlanta 31
Genoa 30
Johannesburg 30
Bremen 29
Boston 27
Brussels 26
Dearborn 26
Pescara 26
Frankfurt am Main 25
Padova 25
Poplar 25
Venice 25
Addison 24
Mountain View 24
Philadelphia 24
Stockholm 24
Cagliari 23
Falkenstein 23
Guangzhou 23
Norwalk 23
Tashkent 22
Charlotte 21
Kunming 21
Ankara 20
Baghdad 20
Jinan 20
Kuala Lumpur 20
Rio de Janeiro 20
Tampa 20
Quito 19
Totale 18.189
Nome #
EPIDEMIOLOGIA, DIAGNOSI E TRATTAMENTO DELLA COMPLICANZA NEOVASCOLARE SOTTORETINICA 1.632
La gestione clinica e riabilitativa del paziente ipovedente 993
Ibuprofen oral administration increases the intraocular pressure-lowering effect of latanoprost in patients with primary open-angle glaucoma 769
Fattori di crescita e cellule staminali 623
PATOLOGIE OCULARI IN RELAZIONE CON LE PROBLEMATICHE DELL’IPOVISIONE 575
Improving visual activity using Gabor patch technology in Stargardt disease: a retrospective study 467
Impact of methylenetetrahydrofolate reductase C677T polymorphism on the efficacy of photodynamic therapy in patients with neovascular age-related macular degeneration 375
ESAME DEL PAZIENTE AFFETTO DA IPOVISIONE 330
A novel mutation of BEST1 gene in Best disease 323
Eredo-distrofia tapeto-retinica e miopia degenerativa: variabilità fenotipica familiare in tre pazienti di razza caucasica 315
Comparative assessment of intraocular inflammation following standard or heavy silicone oil tamponade: a prospective study 284
Psoriatic uveitis is not an exploded myth 283
Torsional phacoemulsification: A pilot study to revise the “harm scale” evaluating the endothelial damage and the visual acuity after cataract surgery 282
Coagulation factor XIIIA (F13A1): Novel perspectives in treatment and pharmacogenetics 280
Effect of factor XIII-A G185T polymorphism on visual prognosis after photodynamic therapy for neovascular macular degeneration 276
Mechanism of inflammation in age-related macular degeneration: an up-to-date on genetic landmarks 258
A pilot study to propose a "Harm Scale", a new method to predict risk of harm to the corneal endothelium caused by longitudinal phacoemulsification, and the subsequent effect of endothelial damage on post operative visual acuity 248
Bilateral isolated acute cataracts in three newly diagnosed insulin dependent diabetes mellitus young patients. 248
Anatomical and functional results of patients with late-stage age-related macular degeneration 6 months after smaller-incision new-generation implantable miniature telescope (SING IMT™) implantation 247
Genetic predictors of response to photodynamic therapy 239
PERDITA ENDOTELIALE DOPO ESTRAZIONE EXTRACAPSULARE DI CATARATTA E FACOEMULSIFICAZIONE IN SITU CON IMPIANTO DI LENTE INTRAOCULARE 233
RETINOPATIA PIGMENTOSA: INQUADRAMENTO CLINICO E TERAPEUTICO 232
Carbonic anhydrase inhibitor topical application and optic nerve head blood supply in primary open-angle glaucoma patients 231
Diabetic macular edema: Safe and effective treatment with intravitreal triamcinolone acetonide (Taioftal) 228
Diabetic retinopathy and endothelin system: Microangiopathy versus endothelial dysfunction 219
MicroRNAs as potential biomarkers and innovative therapeutic targets in retinal degenerations 209
Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications 208
Central serous chorioretinopathy: Pathogenesis and management 205
Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an update 198
Identification of novel X-linked gain-of-function RPGR-ORF15 mutation in Italian family with retinitis pigmentosa and pathologic myopia 194
Attualita sulla retinite pigmentosa 191
Pseudodominant inheritance of retinitis pigmentosa in a family with mutations in the Eyes Shut Homolog (EYS) gene 190
Aflibercept in wet AMD: specific role and optimal use 188
Novel variants of RPGR in X-linked retinitis pigmentosa families and genotype-phenotype correlation 187
Effetti della somministrazione topica di clonidina 0,125% e brimonidina 0,2% sulla pressione di perfusione oculare e sugli indici perimetrici in pazienti in pazienti affetti da glaucoma primario ad angolo aperto 185
Preferential hyperacuity perimetry: perspectives of self-monitoring of neovascular activity in patients with age-related macular degeneration 177
Epiretinal membrane in a 12-year-old immunocompetent girl with cytomegalovirus infection 173
BILATERAL CIRCUMSCRIBED HAEMANGIOMA OF THE CHOROID NOT ASSOCIATED WITH SYSTEMIC VASCULAR SYNDROME. 172
Effects of the passive transfer of anti-gB antibodies in a rabbit model of HSV-1-induced keratitis 171
Effects of 0.005% latanoprost and 0.5% timolol on circadian intraocular pressure variations in patients with normal tension glaucoma 170
Effects of acute topical administration of clonidine 0.125%, apraclonidine 1.0% and brimonidine 0.2% on visual field parameters and ocular perfusion pressure in patients with primary open-angle glaucoma 169
Multiple strokes in a newborn 169
IMMUNIZZAZIONE PASSIVA CON SIERO POLICLONALE NELLA CHERATITE ERPETICA SPERIMENTALE 168
Local and systemic inoculation of DNA or protein gB1s-based vaccines induce a protective immunity against rabbit ocular HSV-1 infection 166
One-Year Safety and Performance Assessment of the Argus II Retinal Prosthesis: A Postapproval Study 165
LA QUALITÀ VISIVA NEI PAZIENTI CANDIDATI AD INTERVENTI DI CHIRURGIA RIFRATTIVA 163
Reproducibility of retinal thickness measurements with retinal thickness analyser in healthy and glaucomatous subjects 161
Topical nonsteroidal anti-inflammatory drugs for macular edema 157
Bilateral central serous chorioretinopathy in a patient treated with systemic cortico-steroids for non-Hodgkin lymphoma 157
CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY ASSOCIATED WITH BILATERAL KERATOCONUS. 157
Intravitreal pegaptanib sodium (Macugen®) for treatment of diabetic macular oedema: A morphologic and functional study 156
Eredo-degenerazioni tapeto-retiniche e cataratta. 156
Dexamethasone Implant Produces Better Outcomes than Oral Acetazolamide in Patients with Cystoid Macular Edema Secondary to Retinitis Pigmentosa 156
Clear cell renal cell carcinoma associated with bilateral atypical acute posterior multifocal placoid pigment epitheliopathy 154
TRATTAMENTO DEL PAZIENTE IPOVEDENTE 154
Are visual disturbances (Excluding diabetic retinopathy) more common in geriatric dm patients? are they risks factor for the progression of disability? 154
Inflammaging: should this term be suitable for age related macular degeneration too? 151
12-month retrospective study and review of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration 151
BILATERAL NEURORETINITIS IN A 6-YEAR-OLD BOY WITH ACQUIRED TOXOPLASMOSIS. 150
Incidence, Risk Factors and Effect on Outcomes of Microcystic Macular Edema after Pars Plana Vitrectomy for Retinal Detachment 150
Optical coherence tomography imaging in the management of the Argus II retinal prosthesis system 149
Gestione clinica della retinite pigmentosa: up-to.date. 147
Circadian changes of intraocular pressure and ocular perfusion pressure after timolol or latanoprost in Caucasians with normal-tension glaucoma 146
VEGF Levels in the Aqueous Humor of Patients With Wet AMD Treated With Intravitreal Bevacizumab. 143
The burden of X-linked retinitis pigmentosa (XLRP) on patient experience and patient-reported outcomes (PROs): findings from the EXPLORE XLRP-2 study 142
Choroidal Changes in Myopic Eyes Affected by Choroidal Neovascularization 142
Peripheral intrastromal hydration facilitates safe, deep trephination in corneas of irregular thickness 141
Predictive role of coagulation-balance gene polymorphisms in the efficacy of photodynamic therapy with verteporfin for classic choroidal neovascularization secondary to age-related macular degeneration 138
Coagulation gene predictors of photodynamic therapy for occult choroidal neovascularization in age-related macular degeneration 137
X-Chromosome Insight for Targeting Gene Therapy 137
Effect of 2% dorzolamide on retinal blood flow: a study on juvenile primary open-angle glaucoma patients already receiving 0.5% timolol. 134
ANOMALIE VASCOLARI RETINICHE NELLA BETA-TALASSEMIA MAJOR 134
Application of artificial intelligence models to predict the onset or recurrence of neovascular age-related macular degeneration 133
Retinitis pigmentosa and cystoid macular pattern 131
Application of artificial intelligence in targeting retinal diseases 131
The influence of diclofenac ophthalmic solution on the intraocular pressure lowering effect of 0.005% latanoprost in glaucomatous patients 130
Effetti della somministrazione topica di brinzolamide 1% sulla pressione di perfusione oculare e sugli indici perimetrici in pazienti in pazienti affetti da glaucoma primario ad angolo aperto: studio in acuto 128
Endogenous Aspergillus versicolor endophthalmitis in an immuno-competent HIV-positive patient 127
ASSESSING THE COST-EFFECTIVENESS OF SWITCHING FROM A BETA-BLOCKER TO LATANOPROST IN THE TREATMENT OF OCULAR HYPERTENSION 126
PATOLOGIE DELL’APPARATO VISIVO 125
MESECTODERMAL LEIOMYOMA EXCLUSIVELY INVOLVING THE POSTERIOR CHOROID. 123
The Impacts of Caregiving for Patients with X-Linked Retinitis Pigmentosa (XLRP): Findings from the EXPLORE XLRP-2 Study 122
Prevalence of factor XIII Val34Leu polymorphism in patients affected by spontaneous subconjunctival hemorrhage 122
Retinitis pigmentosa: genes and disease mechanisms 121
Session-by-Session Prediction of Anti-Endothelial Growth Factor Injection Needs in Neovascular Age-Related Macular Degeneration Using Optical-Coherence-Tomography-Derived Features and Machine Learning 120
null 120
Total aniridia after nonperforating trauma of a pseudophakic eye: ultrasound biomicroscopic findings 120
MODIFICAZIONI DELLA FLORA BATTERICA CONGIUNTIVALE, DEL FILM LACRIMALE E DEGLI ANNESSI OCULARI NEI PAZIENTI ACNEICI IN TERAPIA CON ISOTRETINOINA 116
Denuded Descemet's membrane supports human embryonic stem cell-derived retinal pigment epithelial cell culture 114
SSRIs and intraocular pressure modifications. Evidence, therapeutic implications and possible mechanisms 114
FACOMATOSI 114
Clinical and rehabilitative management of retinitis pigmentosa: up-to-date 112
The heterozygous 20210 G/A genotype prevalence in patients affected by central and branch retinal vein occlusion: a pilot study. 111
Reading performance in patients with retinitis pigmentosa: a study using the MNREAD charts 110
Somministrazione topica di apraclonidina 1,0% e brimonidina 0,2% in pazienti affetti da glaucoma primario ad angolo aperto: effetti sulla pressione di perfusione oculare e sugli indici perimetrici 108
Genetic Features of Uveal Melanoma 107
Quality of life, functioning and participation of children and adolescents with visual impairment: A scoping review 107
null 107
Vitrectomy with macular peeling in eyes with vitreomacular interface disorders and nonexudative age-related macular degeneration 105
Long-Term Follow-Up before and during Riluzole Treatment in Six Patients from Two Families with Spinocerebellar Ataxia Type 7 103
Totale 21.169
Categoria #
all - tutte 116.973
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 8.435
Totale 125.408


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.417 0 0 144 65 63 70 94 77 59 131 181 533
2022/20231.468 178 59 70 150 245 203 65 118 182 42 90 66
2023/20241.407 119 134 82 81 92 104 88 91 52 164 134 266
2024/20254.189 194 138 311 179 427 397 253 291 650 485 504 360
2025/202610.547 944 488 936 1.285 1.439 614 1.126 615 917 1.140 589 454
2026/20271.730 531 669 530 0 0 0 0 0 0 0 0 0
Totale 30.402